Open access
Open access
Powered by Google Translator Translator

Allergy & Immunology

Covid-19: In vitro studies show Pfizer-BioNTech and Moderna vaccines produce fewer antibodies against South African variant

19 Feb, 2021 | 03:01h | UTC

Study 1: Neutralizing Activity of BNT162b2-Elicited Serum — Preliminary Report – New England Journal of Medicine

Study 2: Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine — Preliminary Report – New England Journal of Medicine

Commentaries: Expert reaction to two NEJM Correspondence articles on in vitro studies of the Pfizer-BioNTech and Moderna vaccines and different variants/mutations including mutations on the South Africa variant – Science Media Centre AND Lab studies suggest Pfizer, Moderna vaccines can protect against coronavirus variant – CNN AND Pfizer and Moderna vaccines have reduced effectiveness against South African variant, newly published studies show – The Washington Post AND Pfizer, Moderna vaccines less effective against South African COVID variant – MedicalXpress

 

Commentary on Twitter

 


A food allergy epidemic… or just another case of overdiagnosis?

19 Feb, 2021 | 02:13h | UTC

A food allergy epidemic… or just another case of overdiagnosis? – The BMJ Opinion

Original study: Food anaphylaxis in the United Kingdom: analysis of national data, 1998-2018 – The BMJ

 


Take whatever COVID vaccine you can get. All of them stop death and hospitalization

15 Feb, 2021 | 01:17h | UTC

Take whatever COVID vaccine you can get. All of them stop death and hospitalization – USA Today

“All seven COVID-19 vaccines that have completed large efficacy trials — Pfizer, Moderna, Johnson & Johnson, Novavax, AstraZeneca, Sputnik V and Sinovac — appear to be 100% effective for serious complications. Not one vaccinated person has gotten sick enough to require hospitalization. Not a single vaccinated person has died of COVID-19.”

 


Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US

15 Feb, 2021 | 01:13h | UTC

Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021 – JAMA

Author interview: COVID-19 Vaccine Safety–Anaphylaxis and Allergic Reactions – JAMA

 

Commentary on Twitter

 


Small RCT: Inhaled budesonide reduces the need for hospitalization in COVID-19 patients

11 Feb, 2021 | 02:18h | UTC

Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial – medRxiv

Commentaries: Common asthma treatment reduces need for hospitalisation in COVID-19 patients, study suggests – University of Oxford AND Expert reaction to preprint on an RCT of inhaled budesonide in the treatment of early COVID-19 – Science Media Centre

 


Perspective: Leave your antibodies alone

11 Feb, 2021 | 02:12h | UTC

Leave Your Antibodies Alone – The Atlantic

 


Case report: SARS-CoV-2 evolution in immunocompromised patient treated with convalescent plasma

7 Feb, 2021 | 21:32h | UTC

SARS-CoV-2 evolution during treatment of chronic infection – Nature

 

Commentary on Twitter

 


German 2021 guideline update on acute therapy and management of anaphylaxis

4 Feb, 2021 | 01:17h | UTC

Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update – Allergo Journal International

 


UK Biobank study shows that COVID-19 antibodies remain for at least 6 months post-infection for the vast majority of people who have had the virus

4 Feb, 2021 | 01:32h | UTC

UK Biobank study shows that COVID-19 antibodies remain for at least 6 months post-infection for the vast majority of people who have had the virus – Biobank

Commentary: Covid: Antibodies last at least six months in most – BBC

 


Systematic review: No evidence that patients with asthma are at increased risk of COVID-19 diagnosis, hospitalization or death

4 Feb, 2021 | 01:24h | UTC

Asthma in Adult Patients with COVID-19: Prevalence and Risk of Severe Disease – American Journal of Respiratory and Critical Care Medicine

Commentary: Asthma Patients Get Reassurance on COVID-19 — Research review finds no firm evidence of increased risk for severe illness, death – MedPage Today

 


Covid-19: People who have had infection might only need one dose of mRNA vaccine

3 Feb, 2021 | 01:44h | UTC

Covid-19: People who have had infection might only need one dose of mRNA vaccine – The BMJ

Original preprint studies: Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine – medRxiv AND Single Dose Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2 – medRxiv

 


Safety and effectiveness of bronchial thermoplasty after 10 years in patients with persistent asthma

2 Feb, 2021 | 01:06h | UTC

Safety and effectiveness of bronchial thermoplasty after 10 years in patients with persistent asthma (BT10+): a follow-up of three randomised controlled trials – The Lancet Respiratory Medicine (link to abstract – $ for full-text)

 


CDC Report: Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine

25 Jan, 2021 | 01:29h | UTC

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine — United States, December 21, 2020–January 10, 2021 – CDC Morbidity and Mortality Weekly Report

Commentary: CDC reports rare allergic reactions to Moderna’s Covid-19 vaccine – STAT

 


Clinical update: Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine

22 Jan, 2021 | 08:35h | UTC

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine – JAMA

Author interview: COVID-19 Vaccine Safety–Anaphylaxis and Allergic Reactions

 


Randomized trial: Benralizumab effects on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma

22 Jan, 2021 | 07:59h | UTC

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial – The Lancet Respiratory Medicine (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Study: Immune system ‘remembers’ coronavirus for at least 6 months

20 Jan, 2021 | 01:44h | UTC

Immune system ‘remembers’ coronavirus for at least 6 months: study – MedicalXpress

Original study: Evolution of antibody immunity to SARS-CoV-2 – Nature

 

Commentary on Twitter

 


RECOVERY trial: No Benefit from convalescent plasma in hospitalized patients with Covid-19

17 Jan, 2021 | 22:26h | UTC

RECOVERY trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID-19

Commentary: Covid: ‘Convalescent plasma no benefit to hospital patients’ – BBC

 


Covid-19: Norway investigates 23 deaths in frail elderly patients after vaccination

17 Jan, 2021 | 22:21h | UTC

Covid-19: Norway investigates 23 deaths in frail elderly patients after vaccination – The BMJ

See also: Covid-19 vaccination associated with adverse drug reactions in elderly people who are frail

 


[Preprint] Past COVID-19 infection provides some immunity but people may still carry and transmit virus

15 Jan, 2021 | 09:02h | UTC

Past COVID-19 infection provides some immunity but people may still carry and transmit virus – Public Health England

See also: Covid-19: Past infection provides 83% protection for five months but may not stop transmission, study finds – The BMJ AND COVID reinfections are unusual — but could still help the virus to spread – Nature AND COVID-19 infection gives some immunity, but virus can still be spread, study finds – Reuters AND Expert reaction to a preprint from the SIREN study looking at SARS-CoV-2 infection rates in antibody positive healthcare workers – Science Media Centre

 


Covid-19 Vaccine — Frequently Asked Questions

15 Jan, 2021 | 08:49h | UTC

Covid-19 Vaccine — Frequently Asked Questions – New England Journal of Medicine

 


Clinical trial finds vitamin D does not ward off colds and flu

15 Jan, 2021 | 08:33h | UTC

Clinical trial finds vitamin D does not ward off colds and flu – QIMR Berghofer Medical Research Institute

Original study: The effect of vitamin D supplementation on acute respiratory tract infection in older Australian adults: an analysis of data from the D-Health Trial – The Lancet Diabetes & Endocrinology

 


A guide to vaccinology: from basic principles to new developments

14 Jan, 2021 | 02:09h | UTC

A guide to vaccinology: from basic principles to new developments – Nature Reviews Immunology

 


Guideline: Update on perioperative hypersensitivity reactions

14 Jan, 2021 | 01:44h | UTC

Update on perioperative hypersensitivity reactions: joint document of the Brazilian Society of Anesthesiology (SBA) and Brazilian Association of Allergy and Immunology (ASBAI) – Brazilian Journal of Anesthesiology

Part I: post-crisis guidelines and treatment

Part II: etiology and diagnosis

 


Perspective: Maintaining safety with SARS-CoV-2 vaccines

12 Jan, 2021 | 01:53h | UTC

Maintaining Safety with SARS-CoV-2 Vaccines – New England Journal of Medicine

 

Commentary on Twitter

 


CDC Report: Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine is rare (11.1 cases per million doses)

12 Jan, 2021 | 01:52h | UTC

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020 – CDC Morbidity and Mortality Weekly Report

Commentaries: CDC says severe allergic reactions to coronavirus vaccine are rare – CNN AND CDC reports more allergic reactions to Covid-19 vaccines, but cases remain few – STAT

 


Stay Updated in Your Specialty

No spam, just news.